Trending
- Efficacy and safety of darolutamide plus androgen-deprivation therapy in Black patients with metastatic hormone-sensitive prostate cancer from the phase 3 ARANOTE trial
- 3 Things You Should Know About Frontline and Maintenance Therapy for HER2+ Metastatic Breast Cancer
- RNA binding motif protein RBM41 promotes colorectal tumorigenesis by impeding the maturation of NDRG1 pre-mRNA
- How Do You Choose The Right Frontline Therapy in CLL Care?
- Biopsied lacrimal glands in Japanese cohort: clinical, radiologic and histopathologic analysis
- Non-myeloablative versus reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients aged ≥65: a study from the ALWP of EBMT
- How can we help our fathers live longer?
- Cancer research lab's £6m extra annual cash boost
Sunday, June 21